China Shineway Pharmaceutical Group Limited
CSWYFOTCHealthcare● Active
$1.08
+$0.08(+7.57%)
Market Cap$815832000
P/E Ratio—
52W High$1.08
52W Low$0.9253
China Shineway Pharmaceutical Group Limited（CSWYF）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CSWYF · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $3.14B | $3.78B | $32.00B | $4.03B | $3.17B |
| Cost of Revenue | $0.87B | $0.95B | $7.95B | $1.03B | $0.80B |
| Gross Profit | $2.27B | $2.83B | $24.04B | $3.00B | $2.37B |
| Gross Margin %(computed) | 72.28% | 74.95% | 75.15% | 74.38% | 74.77% |
| Operating Expenses | |||||
| R&D Expenses | $0.10B | $0.10B | $0.78B | $0.12B | $0.11B |
| G&A Expenses | $0.28B | $0.29B | $2.31B | $1.92B | $1.63B |
| Total Operating Expenses | $1.55B | $1.99B | $17.13B | $2.27B | $1.87B |
| Operating Income | $0.72B | $0.84B | $6.91B | $0.73B | $0.53B |
| Operating Margin %(computed) | 22.89% | 22.30% | 21.60% | 18.06% | 16.58% |
| Interest Income | $0.22B | $0.18B | $0.67B | $0.09B | $0.10B |
| Interest Expense | $0.01B | $0.01B | $0.02B | $0.00B | $0.00B |
| Income Before Tax | $1.27B | $1.15B | $1.24B | $0.94B | $0.71B |
| Income Tax Expense | $0.32B | $0.31B | $0.27B | $0.20B | $0.16B |
| Net Income | $0.95B | $0.84B | $0.97B | $0.74B | $0.56B |
| Net Margin %(computed) | 30.30% | 22.24% | 3.04% | 18.30% | 17.55% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $1.26 | $1.11 | $1.28 | $0.96 | $0.74 |
| Wtd Avg Shares | 0.76B | 0.76B | 0.76B | 0.76B | 0.76B |
| EBITDA | $1.35B | $1.22B | $8.87B | $1.00B | $0.77B |
| EBITDA Margin %(computed) | 42.92% | 32.31% | 27.71% | 24.71% | 24.35% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · CNY · B
深入了解China Shineway Pharmaceutical Group Limited
关于China Shineway Pharmaceutical Group Limited（CSWYF）损益表
China Shineway Pharmaceutical Group Limited（CSWYF）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，CSWYF实现营收$3.14B，毛利润$2.27B（毛利率72.28%），净利润$0.95B（净利率30.30%）。
常见问题
CSWYF · 4 问China Shineway Pharmaceutical Group Limited（CSWYF）2025财年营收为$3.14B，同比down17.0%。
CSWYF revenueCSWYF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09